Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03926286 · ClinicalTrials.gov registry record · Phase 1
Fecal Microbial Transplant (FMT) for Sjogrens Syndrome
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT03926286 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 10 participants.
The verdict
NCT03926286, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is an open label study to evaluate the effect of Fecal Microbiota Transplantation (FMT) on the gut microbiome and Systemic parameters.
Interventions
- DRUG FMP-30
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2020-06-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03926286
The ClinicalTrials.gov registry entry for NCT03926286 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FMP-30 is the first listed.
NCT03926286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03926286 about?
NCT03926286 is a clinical study titled "Fecal Microbial Transplant (FMT) for Sjogrens Syndrome". This is an open label study to evaluate the effect of Fecal Microbiota Transplantation (FMT) on the gut microbiome and Systemic parameters.
What is the current status of trial NCT03926286?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2019-04-15. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT03926286?
The interventions under investigation include: FMP-30 (DRUG).
Who is sponsoring clinical trial NCT03926286?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.